Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 JUN 8 ... Biovest International, Inc. (Other OTC:BVTI), a majority-owned subsidiary of AccentiaBiopharmaceuticals, Inc. (Other OTC:ABPIQ), announced that BiovaxID®, Biovest’s ...
2009 FEB 23 ... included asset impairment charges of $7.0 million, or $0.04 per share, resulting from AccentiaBiopharmaceuticals, Inc.’s bankruptcy filing in November 2008. Excluding these charges, ...
2008 APR 28 ... Therapy, Treatment, U.S. Food and Drug Administration, Vaccination, Lymphoma Vaccine, Accentia Biopharmaceuticals Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 NOV 17 ... Keywords: Biopharmaceuticals, Drugs, Pharmaceuticals, Therapies, Accentia Biopharmaceuticals Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 NOV 24 ... Neuroimmunology, Neurology, Oncology, Pharmaceuticals, Therapies, Therapy, Treatment, Accentia Biopharmaceuticals Inc.
This article was prepared by Pain & Central Nervous System Week editors ...
2008 APR 7 ... in the
Keywords: Biopharmaceuticals, Drugs, Pharmaceuticals, Therapies, Accentia Biopharmaceuticals Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 NOV 10 ... Immunization, Non-Hodgkin Lymphoma, Oncology, Pharmaceuticals, Therapies, Vaccination, Accentia Biopharmaceuticals Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 JUL 14 ... Keywords: Biopharmaceuticals, Drugs, Pharmaceuticals, Therapies, Accentia Biopharmaceuticals Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 AUG 25 ... Keywords: Biopharmaceuticals, Drugs, Pharmaceuticals, Therapies, Accentia Biopharmaceuticals Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 JUL 7 ... Multiple Sclerosis, Stem Cell Research, Therapies, Therapy, Treatment, Urology, Accentia Biopharmaceuticals Inc.
This article was prepared by Pain & Central Nervous System Week editors ...
2008 AUG 18 ... Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of AccentiaBiopharmaceuticals, Inc. (NASDAQ:ABPI), announced that Biovest has been designated one ...
2008 APR 28 ... Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of AccentiaBiopharmaceuticals, Inc. (NASDAQ:ABPI), reported that the Baltimore Sun has published an ...
2008 APR 28 ... Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of AccentiaBiopharmaceuticals, Inc. (NASDAQ:ABPI), announced that a key milestone has been achieved ...
2008 MAY 5 ... Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of AccentiaBiopharmaceuticals, Inc. (NASDAQ:ABPI), announced that its Chairman and CEO, Dr. Steven ...
2008 MAY 5 ... trials for PPD's statin compound for the treatment of dyslipidemia. In March 2008, AccentiaBiopharmaceuticals, Inc. announced the results of its SinuNase(TM) Phase III clinical ...
2008 MAY 12 ... Neurology, Otolaryngology, Pharmaceuticals, Sinusitis, Therapies, Therapy, Treatment, Accentia Biopharmaceuticals Inc.
This article was prepared by Pain & Central Nervous System Week editors ...
